UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

Journal of vascular surgery, 2014-09, Vol.60 (3), p.686-695.e2

2014

Volltextzugriff (PDF)

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

The New England journal of medicine, 2017-01, Vol.376 (1), p.32-40

2017

Volltextzugriff (PDF)

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502

2016

Volltextzugriff (PDF)

Rivaroxaban in Peripheral Artery Disease after Revascularization

The New England journal of medicine, 2020-05, Vol.382 (21), p.1994-2004

2020

Volltextzugriff (PDF)

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

The New England journal of medicine, 2013-10, Vol.369 (14), p.1285-1287

2013

Volltextzugriff (PDF)

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Thrombosis and haemostasis, 2020-05, Vol.120 (5), p.866-875

2020

Volltextzugriff (PDF)

Reducing LDL with PCSK9 Inhibitors — The Clinical Benefit of Lipid Drugs

The New England journal of medicine, 2015-10, Vol.373 (17), p.1588-1591

2015

Volltextzugriff (PDF)

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Vascular medicine (London, England), 2020-04, Vol.25 (2), p.103-105

Hiatt, William R

2020

Volltextzugriff (PDF)

Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options

Journal of the American College of Cardiology, 2016-03, Vol.67 (11), p.1338-1357

2016

Volltextzugriff (PDF)

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

The American heart journal, 2018-12, Vol.206, p.80-93

2018

Volltextzugriff (PDF)

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Catheterization and cardiovascular interventions, 2015-10, Vol.86 (4), p.611-625

2015

Volltextzugriff (PDF)

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2019-01, Vol.139 (4), p.e10-e33

2019

Volltextzugriff (PDF)

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Circulation (New York, N.Y.), 2017-01, Vol.135 (3), p.241-250

2017

Volltextzugriff (PDF)

Antithrombotic Therapy for Peripheral Artery Disease in 2018

JAMA : the journal of the American Medical Association, 2018-06, Vol.319 (22), p.2329

2018

Volltextzugriff (PDF)

Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease

Circulation research, 2015-04, Vol.116 (9), p.1527-1539

2015

Volltextzugriff (PDF)

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

Diabetologia, 2019-06, Vol.62 (6), p.926-938

2019

Volltextzugriff (PDF)

Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess?

Diabetes care, 2016-05, Vol.39 (5), p.738-742

2016

Volltextzugriff (PDF)

Inflammatory Cytokines Associated With Failure of Lower Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes

Diabetes care, 2019-10, Vol.42 (10), p.1939-1945

2019

Volltextzugriff (PDF)

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2534-2555

2017

Volltextzugriff (PDF)

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Circulation (New York, N.Y.), 2019-08, Vol.140 (7), p.556-565

2019

Volltextzugriff (PDF)

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

The American heart journal, 2018-05, Vol.199, p.83-91

2018

Volltextzugriff (PDF)

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

The New England journal of medicine, 2020-11, Vol.383 (21), p.2090-2091

2020

Volltextzugriff (PDF)

Cardiovascular Drug Development

Journal of the American College of Cardiology, 2015-04, Vol.65 (15), p.1567-1582

2015

Volltextzugriff (PDF)

PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes

Annual review of medicine, 2018-01, Vol.69 (1), p.133-145

2018

Volltextzugriff (PDF)

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

Journal of the American College of Cardiology, 2015-03, Vol.65 (9), p.931-941

2015

Volltextzugriff (PDF)

1 – 25 von 466

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(375)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(465)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(257)
Life Sciences & Biomedicine
(251)
Humans
(213)
Cardiovascular System & Cardiology
(138)
Male
(104)
Female
(102)
Cardiac & Cardiovascular Systems
(87)
Peripheral Vascular Disease
(80)
Middle Aged
(70)
Aged
(67)
Risk Factors
(60)
Peripheral Artery Disease
(58)
Treatment Outcome
(46)
Cardiovascular Disease
(37)
General & Internal Medicine
(35)
Medicine, General & Internal
(34)
Surgery
(31)
Adult
(30)
Peripheral Arterial Disease - Drug Therapy
(30)
United States
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Rivaroxaban in Peripheral Artery Disease after Revascularization

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Reducing LDL with PCSK9 Inhibitors — The Clinical Benefit of Lipid Drugs

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Antithrombotic Therapy for Peripheral Artery Disease in 2018

Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess?

Inflammatory Cytokines Associated With Failure of Lower Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

Cardiovascular Drug Development

PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

Aktive Filter

Suchergebnisse filtern